Gene Engineering Technology Platform

Genomtec’s platform technology enables fast and precise molecular analysis outside the laboratory environment without the need for qualified laboratory personnel. The solution utilises microfluidic technology and a proprietary lab-on-a-chip reaction card. Proprietary SNAAT® (Streamlined Nucleic Acid Amplification Technology) allows the detection of targeted DNA or RNA fragments in as little as 15 minutes, while maintaining effectiveness and performance comparable to currently used lab-based PCR methods. Genomtec serves the Clinical Diagnostics, Life Sciences, Veterinary, Food Safety, and Biosecurity markets. The company holds more than 5 patents and 3-5 trademarks.

Comprehensive technology transfer platform enabling laboratories to establish in-house genetic testing services using proprietary Medicover Genetics technology and validated protocols. Supports integration of multiple genetic testing applications in single sequencing workflows.

Technology platform for developing and testing microphysiological systems that simulate human organ and tissue behavior in vitro. Enables preclinical drug testing, toxicology assessment, and disease modeling with improved physiological relevance compared to conventional cell cultures. Integrates microfluidics, tissue engineering, and analytical capabilities for pharmaceutical and biomedical research applications.